Colleyville Drug, Inc

Community/Retail Pharmacy



  
  622 W Main St, Crosbyton
Texas, 79322-2243

 806-675-2001    806-675-7284
Colleyville Drug, Inc is a Community/Retail Pharmacy in Crosbyton, Texas. It is located at 622 W Main St, Crosbyton and it's customer support contact number is 806-675-2001. The authorized person of Colleyville Drug, Inc is Mr. Clint Tyler Manske, RPH who is Owner of the pharmacy and his contact number is 806-549-1243. Colleyville Drug, Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Colleyville Drug, Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.


Pharmacy Details:
Colleyville Drug, Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Colleyville Drug, Inc
Type: Community/Retail Pharmacy
Location:622 W Main St, Crosbyton,
Texas, 79322-2243
Phone:806-675-2001
Fax:806-675-7284
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Mr. Clint Tyler Manske
Credentials: RPH
Position: Owner
Contact Number: 806-549-1243
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1710990387
NPI Enumeration Date: 14 Aug, 2006
NPI Last Update On: 19 Jul, 2024

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Colleyville Drug, Inc are as mentioned below.
SpecializationLicense NumberStateStatus
Community/Retail Pharmacy Primary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
148716MedicaidTexas
Medicare Enrollment:
Colleyville Drug, Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
6507828555O20041101001234Colleyville Drug Inc.PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY)
6507828555O20100930040159Colleyville Drug Inc.DME SUPPLIER - PHARMACY
Products Available:
Colleyville Drug, Inc has following products available for sale under medicare.
Products:
•  Blood Glucose Monitors & Supplies: Non-mail Order•  Canes & Crutches
•  Commodes, Urinals, & Bedpans•  Diabetic Shoes & Inserts: Custom Fabricated
•  Diabetic Shoes & Inserts: Prefabricated•  Orthoses: Off-the-shelf
•  Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 622 W Main St,
Crosbyton, Texas
Zip: 79322-2243
Phone Number: 806-675-2001
Fax Number: 806-675-7284
Patients can reach Colleyville Drug, Inc at 622 W Main St, Crosbyton, Texas or can call on customer care at 806-675-2001.
Comments/ Reviews:
Read all the reviews posted for Colleyville Drug, Inc below. You may also share your own experience with Colleyville Drug, Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.